Intracerebroventricular infusion of pentoxifylline significantly reduced left ventricular end-diastolic pressure (10 vs 21 mmHg) and neurohumoral excitation in rats with heart failure.
Does intracerebroventricular pentoxifylline reduce neurohumoral excitation in rats with ischemia-induced heart failure?
Inhibition of brain proinflammatory cytokine synthesis reduces neurohumoral excitation by downregulating the brain renin-angiotensin system and HPA axis in rats with ischemia-induced heart failure.
Absolute Event Rate: 10% vs 21%
p-value: p=<0.05
The expression of proinflammatory cytokines increases in the hypothalamus of rats with heart failure (HF). The pathophysiological significance of this observation is unknown. We hypothesized that hypothalamic proinflammatory cytokines upregulate the activity of central neural systems that contribute to increased sympathetic nerve activity in HF, specifically, the brain renin-angiotensin system (RAS) and the hypothalamic-pituitary-adrenal (HPA) axis. Rats with HF induced by coronary ligation and sham-operated controls (SHAM) were treated for 4 wk with a continuous intracerebroventricular infusion of the cytokine synthesis inhibitor pentoxifylline (PTX, 10 microg/h) or artificial cerebrospinal fluid (VEH). In VEH-treated HF rats, compared with VEH-treated SHAM rats, the hypothalamic expression of proinflammatory cytokines was increased, along with key components of the brain RAS (renin, angiotensin-converting enzyme, angiotensin type 1 receptor) and corticotropin-releasing hormone, the central indicator of HPA axis activation, in the paraventricular nucleus (PVN) of the hypothalamus. The expression of other inflammatory/excitatory mediators (superoxide, prostaglandin E(2)) was also increased, along with evidence of chronic neuronal excitation in PVN. VEH-treated HF rats had higher plasma levels of norepinephrine, ANG II, interleukin (IL)-1beta, and adrenocorticotropic hormone, increased left ventricular end-diastolic pressure, and increased wet lung-to-body weight ratio. With the exception of plasma IL-1beta, an indicator of peripheral proinflammatory cytokine activity, all measures of neurohumoral excitation were significantly lower in HF rats treated with intracerebroventricular PTX. These findings suggest that the increase in brain proinflammatory cytokines observed in rats with ischemia-induced HF is functionally significant, contributing to neurohumoral excitation by activating brain RAS and the HPA axis.
Kang et al. (Sat,) conducted a other in Ischemia-induced heart failure (n=56). Pentoxifylline vs. Artificial cerebrospinal fluid (vehicle) was evaluated on Left ventricular end-diastolic pressure (LVEDP) at 4 weeks (p=<0.05). Intracerebroventricular infusion of pentoxifylline significantly reduced left ventricular end-diastolic pressure (10 vs 21 mmHg) and neurohumoral excitation in rats with heart failure.